These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10746673)

  • 1. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases.
    Bussaglia E; del Rio E; Matias-Guiu X; Prat J
    Hum Pathol; 2000 Mar; 31(3):312-7. PubMed ID: 10746673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations of the PTEN/NMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer.
    Hirai Y; Tanaka N; Furuta R; Kawaguchi T; Sakamoto M; Shirahama S; Noda T
    Gynecol Oncol; 2001 Oct; 83(1):81-8. PubMed ID: 11585417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
    Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
    Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
    Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
    Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: evidence for a tumor progression role in endometrial carcinomas with microsatellite instability.
    Catasús L; Matias-Guiu X; Machin P; Muñoz J; Prat J
    Lab Invest; 1998 Nov; 78(11):1439-44. PubMed ID: 9840618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.
    Konopka B; Paszko Z; Janiec-Jankowska A; Goluda M
    Cancer Lett; 2002 Apr; 178(1):43-51. PubMed ID: 11849740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes and consequences of microsatellite instability in endometrial carcinoma.
    Gurin CC; Federici MG; Kang L; Boyd J
    Cancer Res; 1999 Jan; 59(2):462-6. PubMed ID: 9927063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN mutations and evolving concepts in endometrial neoplasia.
    Latta E; Chapman WB
    Curr Opin Obstet Gynecol; 2002 Feb; 14(1):59-65. PubMed ID: 11801878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas.
    Wappenschmidt B; Wardelmann E; Gehrig A; Schöndorf T; Maass N; Bonatz G; Gassel AM; Pietsch T; Mallmann P; Weber BH; Schmutzler RK
    Hum Pathol; 2004 Oct; 35(10):1260-5. PubMed ID: 15492994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
    Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
    Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
    Konopka B; Janiec-Jankowska A; Kwiatkowska E; Najmoła U; Bidziński M; Olszewski W; Goluda C
    Hum Pathol; 2011 Nov; 42(11):1710-9. PubMed ID: 21531001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma.
    Konopka B; Janiec-Jankowska A; Paszko Z; Goluda M
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):114-21. PubMed ID: 14663583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
    Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
    Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
    Tashiro H; Blazes MS; Wu R; Cho KR; Bose S; Wang SI; Li J; Parsons R; Ellenson LH
    Cancer Res; 1997 Sep; 57(18):3935-40. PubMed ID: 9307275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared to sporadic microsatellite unstable tumors.
    Zhou XP; Kuismanen S; Nystrom-Lahti M; Peltomaki P; Eng C
    Hum Mol Genet; 2002 Feb; 11(4):445-50. PubMed ID: 11854177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
    Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability.
    Cohn DE; Basil JB; Venegoni AR; Mutch DG; Rader JS; Herzog TJ; Gersell DJ; Goodfellow PJ
    Gynecol Oncol; 2000 Oct; 79(1):101-6. PubMed ID: 11006040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.